Since 2011 , Ligand Pharmaceuticals tripled its stocks and doubled its revenue to $65 million .
After Ligand Pharmaceuticals hired John Higgins as its new CEO in January 2007 , Third Point Management invested in the biotech firm and was able to cut its losses .
Since 2011 , Ligand Pharmaceuticals tripled Ligand Pharmaceuticals ' stocks and doubled its revenue to $65 million .
After Ligand Pharmaceuticals hired John Higgins as its new CEO in January 2007 , Third Point Management invested in the biotech firm and was able to cut its losses .